Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography

The prime toxic species that causes Alzheimer’s disease is believed to be oligomeric aggregates of the amyloid β peptide (Aβ). The major aim of the work was to develop methods to study which proteins in human plasma that interacts with oligomeric neurotoxic forms of Aβ. The interactions of Aβ with h...

Descripción completa

Detalles Bibliográficos
Autor principal: Das, Anuj Kumer
Formato: Second cycle, A2E
Lenguaje:sueco
Inglés
Publicado: 2012
Materias:
Acceso en línea:https://stud.epsilon.slu.se/5093/
_version_ 1855570787055960064
author Das, Anuj Kumer
author_browse Das, Anuj Kumer
author_facet Das, Anuj Kumer
author_sort Das, Anuj Kumer
collection Epsilon Archive for Student Projects
description The prime toxic species that causes Alzheimer’s disease is believed to be oligomeric aggregates of the amyloid β peptide (Aβ). The major aim of the work was to develop methods to study which proteins in human plasma that interacts with oligomeric neurotoxic forms of Aβ. The interactions of Aβ with human biological fluid proteins are important for drug discovery efforts against Alzheimer’s disease but still not very well explored. Stable peptide oligomers were formed by a special variant of Aβ (called Aβ42cc). The co-elution of Aβ42cc oligomers with human blood serum was carried out using size exclusion chromatography (SEC). The eluted fractions were analyzed by SDS-PAGE but no strong interaction between Aβ oligomers and blood serum proteins could be observe.
format Second cycle, A2E
id RepoSLU5093
institution Swedish University of Agricultural Sciences
language Swedish
Inglés
publishDate 2012
publishDateSort 2012
record_format eprints
spelling RepoSLU50932012-11-28T12:03:14Z https://stud.epsilon.slu.se/5093/ Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography Das, Anuj Kumer Life sciences Chemistry The prime toxic species that causes Alzheimer’s disease is believed to be oligomeric aggregates of the amyloid β peptide (Aβ). The major aim of the work was to develop methods to study which proteins in human plasma that interacts with oligomeric neurotoxic forms of Aβ. The interactions of Aβ with human biological fluid proteins are important for drug discovery efforts against Alzheimer’s disease but still not very well explored. Stable peptide oligomers were formed by a special variant of Aβ (called Aβ42cc). The co-elution of Aβ42cc oligomers with human blood serum was carried out using size exclusion chromatography (SEC). The eluted fractions were analyzed by SDS-PAGE but no strong interaction between Aβ oligomers and blood serum proteins could be observe. 2012-11-27 Second cycle, A2E NonPeerReviewed application/pdf sv https://stud.epsilon.slu.se/5093/11/das_a_k_121128.pdf Das, Anuj Kumer, 2012. Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography. Second cycle, A2E. Uppsala: (NL, NJ) > Dept. of Molecular Biology (until 131231) <https://stud.epsilon.slu.se/view/divisions/4025.html> urn:nbn:se:slu:epsilon-s-1890 eng
spellingShingle Life sciences
Chemistry
Das, Anuj Kumer
Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title_full Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title_fullStr Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title_full_unstemmed Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title_short Proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
title_sort proteomics studies of neurotoxic amyloid β oligomers using size exclusion chromatography
topic Life sciences
Chemistry
url https://stud.epsilon.slu.se/5093/
https://stud.epsilon.slu.se/5093/